Hairy cell leukaemia: a heterogeneous disease?

The US National Cancer Institute’s Surveillance, Epidemiology and End Results program was used to develop aetiological clues for hairy cell leukaemia (HCL). Descriptive techniques (age‐adjusted incidence trends, age‐specific incidence rates (IR), and age distributions‐at‐diagnosis) were supplemented with mathematical models (two‐component mixture, generalized linear regression, and age‐period‐cohort). There were 2856 cases of HCL diagnosed during 1978–2004 (IR 0·32/100 000 person‐years). IRs were nearly 4‐fold greater among men than women and more than 3‐fold higher for Whites than Blacks. Temporal trends were stable over time. Age‐specific IRs increased rapidly until approximately 40 years then rose at a slower pace. The age‐specific IR curves reflected bimodal early‐ and late‐onset age distributions‐at‐diagnosis (or density plots), with some variation by gender. Among both men and women, a two‐component mixture model fitted the data better than a single density or cancer population. Age‐period‐cohort models confirmed statistically significant age‐related effects after full adjustment for temporal trends (calendar‐period and birth‐cohort effects). In summary, age incidence patterns (rates and bimodal densities) suggested that HCL is a heterogeneous disease, consisting of at least two underlying subgroups and/or cancer populations by age‐at‐onset. Distinct early‐ and late‐onset HCL populations may reflect different age‐related causal pathways, risk factor profiles, and/or stem cells of origin.

[1]  S. Devesa,et al.  Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology , 2007, British journal of haematology.

[2]  Bingshu E. Chen,et al.  Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers , 2007, Cancer Causes & Control.

[3]  R. Pfeiffer,et al.  Shifting breast cancer trends in the United States. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  B Carstensen,et al.  Age–period–cohort models for the Lexis diagram , 2007, Statistics in medicine.

[5]  Bingshu E. Chen,et al.  Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions , 2007, Cancer Causes & Control.

[6]  O. Paltiel,et al.  A population‐based study of hairy cell leukemia in Israel , 2006, European journal of haematology.

[7]  M. Sherman,et al.  Comparison of Age Distribution Patterns for Different Histopathologic Types of Breast Carcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.

[8]  E. Feuer,et al.  Changing patterns in breast cancer incidence trends. , 2006, Journal of the National Cancer Institute. Monographs.

[9]  J. Bay,et al.  Two new cases of familial hairy cell leukemia associated with HLA haplotypes A2, B7, Bw4, Bw6 , 2005, Leukemia & lymphoma.

[10]  R. Jarrett Risk Factors for Hodgkin's Lymphoma by EBV Status and Significance of Detection of EBV Genomes in Serum of Patients with EBV-Associated Hodgkin's Lymphoma , 2003, Leukemia & lymphoma.

[11]  R. Sharpe,et al.  Pathology of hairy-cell leukaemia. , 2003, Best practice & research. Clinical haematology.

[12]  A. Polliack Hairy cell leukemia: biology, clinical diagnosis, unusual manifestations and associated disorders. , 2002, Reviews in clinical and experimental hematology.

[13]  J. Gurney,et al.  Decreasing incidence rates of primary central nervous system lymphoma , 2002, Cancer.

[14]  D. Hossfeld E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .

[15]  P. Wiernik,et al.  Hairy cell leukemia in first cousins and review of the literature , 2001, European journal of haematology.

[16]  K. Wong,et al.  Hairy cell leukemia in Hong Kong Chinese: a 12‐year retrospective survey , 2000, Hematological oncology.

[17]  A. Saven,et al.  Treatment of hairy cell leukemia-variant with cladribine. , 1999, Leukemia & lymphoma.

[18]  M. Fredrikson,et al.  Previous medical history and medications as risk factors for hairy cell leukaemia. , 1999, Oncology reports.

[19]  P. Boyle,et al.  Age-period-cohort analysis of chronic disease rates. I: Modelling approach. , 1998, Statistics in medicine.

[20]  L. Hardell,et al.  Occupational exposures, animal exposure and smoking as risk factors for hairy cell leukaemia evaluated in a case-control study. , 1998, British Journal of Cancer.

[21]  D. Hémon,et al.  Farming, pesticide use and hairy-cell leukemia. , 1996, Scandinavian journal of work, environment & health.

[22]  P. Hartge,et al.  Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. , 1996, Journal of the National Cancer Institute.

[23]  G. Flandrin,et al.  Hairy cell leukaemia, occupation, and smoking , 1995, British journal of haematology.

[24]  T. Fears,et al.  Graphical presentation of trends in rates. , 1995, American journal of epidemiology.

[25]  M. Dimopoulos,et al.  Waldenström's macroglobulinemia. , 1994, Hematology/oncology clinics of North America.

[26]  A. Staines,et al.  Hairy cell leukaemia: descriptive epidemiology and a case‐control study , 1993, British journal of haematology.

[27]  R. Randles,et al.  Introduction to the Theory of Nonparametric Statistics , 1991 .

[28]  D. Catovsky,et al.  A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients. , 1990, Blood.

[29]  L. Bernstein,et al.  Epidemiology of hairy cell leukemia in Los Angeles County. , 1990, Cancer research.

[30]  P. Levy,et al.  A case-control inquiry into the etiology of hairy cell leukemia. , 1985, American journal of epidemiology.

[31]  G. Schwarz Estimating the Dimension of a Model , 1978 .

[32]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[33]  J. Holý,et al.  [Epidemiology of Hodgkin's disease]. , 1977, Ceskoslovenska pediatrie.

[34]  馬場 謙介,et al.  Manual of Tumor Nomenclature and Coding(MOTNAC)による剖検例検索システム (第12回日本癌治療学会特別講演・シンポジウム ) -- (癌診療における情報処理の役割(シンポジウム)) , 1975 .

[35]  N. Gutensohn,et al.  Epidemiology of Hodgkin's disease. , 1972, Seminars in oncology.

[36]  C. Li,et al.  Leukemic Reticuloendotheliosis: The Role of Tartrate-Resistant Acid Phosphatase in Diagnosis and Splenectomy in Treatment , 1972 .

[37]  Brian Macmahons Epidemiological evidence on the nature of hodgkin's disease , 1957 .

[38]  M. Berwick,et al.  Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. , 2008, The Journal of investigative dermatology.

[39]  D. Weisenburger,et al.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. , 2006, Blood.

[40]  G. Eyjolfsson,et al.  Epidemiology of hairy cell leukemia in Iceland. , 2002, The hematology journal : the official journal of the European Haematology Association.

[41]  N. Chatterjee,et al.  Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  D. Catovsky,et al.  The natural history and clinico-pathological features of the variant form of hairy cell leukemia , 2001, Leukemia.

[43]  M. Gail,et al.  Probability of helicobacter pylori infection based on IgG levels and other covariates using a mixture model. , 2000, Journal of epidemiology and biostatistics.

[44]  A. M. Polianskaia,et al.  [Hairy cell leukemia]. , 1983, Gematologiia i transfuziologiia.

[45]  H. Akaike,et al.  Information Theory and an Extension of the Maximum Likelihood Principle , 1973 .

[46]  B. Macmahon,et al.  Epidemiology: Principles and Methods , 1970 .

[47]  B. Macmahon,et al.  Epidemiological evidence on the nature of hodgkin's disease , 1957 .